1243357-84-7Relevant academic research and scientific papers
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis
Vajs, Jure,Proud, Conor,Brozovic, Anamaria,Gazvoda, Martin,Lloyd, Adrian,Roper, David I.,Osmak, Maja,Ko?mrlj, Janez,Dowson, Christopher G.
, p. 223 - 234 (2017/01/10)
Diaryltriazene derivatives were synthesized and evaluated for their antimicrobial properties. Initial experiments showed some of these compounds to have activity against both methicillin-resistant strains of Staphylococus aureus (MRSA) and Mycobacterium s
Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents
?imbora-Zovko, Tamara,Brozovic, Anamaria,Piantanida, Ivo,Fritz, Gerhard,Virag, Andrej,Ali?, Branko,Majce, Vita,Ko?evar, Marijan,Polanc, Slovenko,Osmak, Maja
experimental part, p. 2971 - 2983 (2011/07/09)
We describe the synthesis and biological activity of a new class of 1,3-diaryltriazenes, namely 4-nitro-substituted 1,3-diaryltriazenes. Structure-activity relationship analysis reveals that 1,3-diaryltriazenes can be modified from inactive to highly cyto
ANALOGUES OF 1,3-BIS(4-NITROPHENYL)TRIAZENES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND N-ACYL DERIVATIVES FOR TUMOUR TREATMENT
-
Page/Page column 10, (2010/10/03)
The present invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for the treatment of different types of tumours. Said compounds show cytotoxicity at very low concentrations (ICs
